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Defective Chemokine Production in T-Leukemia Cell
Lines and its Possible Functional Role
JYRKI IVANOFF, ANNA IVANOFF and KARL-GOSTA SUNDQVIST*
Department of Clinical Immunology, University of Umegt, S-901 85 Umegt, Sweden
Peripheral blood lymphocytes and T-cell clones produced nanogram quantities of the chem-
okines RANTES, MIP-lt, MIP-I[3, MCP-1, IL-8 and GRO-(x as well as the motogenic
cytokine HGE In contrast, various T-leukemia ceil lines at different stages of differentiation
did not produce the same chemokines/cytokines. In order to study the possible functional
importance of the poor chemokine production different T-cell lines were compared with
respect to development of motile forms and migration on extracellular matrix components in
the absence and presence of various chemokines. RANTES, MIP-1, MIP-1 [, IL-8, GRO-o
and lymphotactin did not augment the development of motile forms including the size and
appearance of the pseudopodia activity of the T-leukemia cell lines. The T-cell lines migrated
spontaneously on/to fibronectin in a Boyden chamber assay system. Chemokines augmented
the migration of the T-leukemia cell lines on fibronectin in the Boyden system in a chemotac-
tic fashion with peak responses at 10 to 50 ng/ml. Thus, the production of chemokines is
defective, in neoplastic T-lymphocytes. The defective chemokine production does not seem to
play any major role for the basic locomotor capacity of the cells but may modulate the
responsiveness to exogenous chemokines.
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Abbreviations:ECM, extracellular matrix, C IV, collagen type IV, FN, Fibronectin, LM, laminin, ICAM,
intercellular adhesion molecule, VCAM, vascular cell adhesion molecules, TPA, 12-o-tetradecanoyl
phorbol-13-acetate, HPF, high power field, IL-8, Interleukin -8, RANTES, regulated on activation nor-
mal T-cell expressed and secreted, MCP-1, -2, -3, Monocyte chemotactic protein-1 -2, -3, MIP-lct,
-1, Macrophage inflammatory protein-let, -1[, GRO-ct, Growth-related oncogene ct, IFN-7, iner-
feron-7, TNF-t, Tumor necrosis factor-a, HGF, Hepatocyte Growth factor, SLC, secondary lym-
phoid-tissue chemokine, FCS, fetal calf serum, PBL, peripheral blood lymphocytes
INTRODUCTION
T-lymphocytes infiltrate tissues during inflammatory
conditions of autoimmune and allergic origin and
after neoplastic transformation as in Sezary’s syn-
drome and Mycosis Fungoides(1-3). Since the capac-
ity of T-lymphocytes to infiltrate plays a fundamental
role in a variety of disease processes it is important to
elucidate the regulation of T-cell infiltration. T-leuke-
mia cell lines representing different stages of differen-
tiation provide useful tools for this purpose.
Furthermore, it is also important to elucidate whether
motility per se or migration on tissue components is
normal or altered in neoplastic conditions affecting
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T-cells. The present work focus on basic locomotor
capacity and migration of T-leukemia cell lines on
extracellular matrix (ECM) components.
The capacity of T-lymphocytes to migrate and infil-
trate depends on the coordination of locomotor proper-
ties per se and adhesive interactions with endothelia and
components of the extracellular matrix (ECM). T-cell
infiltration comprises the adhesion of circulating lym-
phocytes to vascular endothelium followed by transend-
othelial passage and migration through the ECM (4-6).
To enter sites of inflammation circulating lymphocytes
use 2(LFA-1) and [1 (4 and o5) integrins to bind and
migrate through endothelium that has been activated to
express ICAM-1 and VCAM-1 by the local release of
cytokines such as IL-1, TNF-cz or IFN-y (6,7). Addi-
tional targeting of T-cells to specific tissue sites is pro-
vided by receptors such as the cutaneous
lymphocyte-associated antigen CLA which recognizes
E-selectin on endothelial cells and is thought to be
responsible for skin homing of T-cells (8).
During extravasation T-cells probably interact with
ECM-components such as collagen type IV within the
endothelial basement membrane (9-11) and after pas-
sage of the endothelium inflammatory T-cells migrate
and accumulate in, an environment containing
fibronectin (12-14). The extravascular migration of
T-cells thus occurs in a milieu of ECM-proteins and
probably involves sequential adhesion and deadhe-
sion of lymphocyte [31-integrins with the matrix com-
ponents (10,15). There is experimental evidence from
in vitro models of lymphocyte migration that T-cells
attach to and display motile behavior on ECM-com-
ponents (16). Lymphocytes can thus migrate on the
ECM-components FN, C IV and LM in a hapto- and
chemotactic fashion. This migration is mediated by
[31-integrins which also together with 2-integrins
function as triggering receptors for T-cell migration
(10,17,18). Furthermore, there seems to be a func-
tional specialization for T-cell migration to FN in that
different T-cell lines use either 41 or c5[3for
migration although they use both integrins for adhe-
sion (16).
The ability of T-lymphocytes to migrate through
extravascular tissues towards a site of anti-
genic/inflammatory challenge is probably dependent
on the ability of the cells to respond to a chemotactic
gradient. The chemokines, a superfamily of small
proteins (8000-14000 Mw) secreted primarily by leu-
kocytes, are likely regulators of T-cell recruitment and
infiltration during inflammation (19-30). The super-
family of chemokines is classified as the C-X-C (),
C-C (), C (y)- and the membrane bound CX3C
(6)-groups, as defined by the spacing of the first two
cysteines in a conserved four-cystein motif (30-35).
The chemokines probably influence both extravascu-
lar T-cell migration and the extravasation step per se.
Thus, MCP-1 has been demonstrated to induce
transendothelial T-cell chemotaxis (24,25). RANTES,
MIP-I and MIP-I have been shown to be T-cell
attractants using the Boyden microchemotaxis cham-
ber (19,20,26,27). One plausible mechanism of action
Of the chemokines is that they regulate T-cell adhe-
sion. Thus, MIP-Iz, MIP-I, RANTES and
IFN-y-inducible protein have been reported to aug-
ment adhesion of peripheral blood T-lymphocytes to
recombinant endothelial adhesion molecules and to
purified ECM-proteins (26,27). However, the recently
described chemokines SLC (secondary lymphoid tis-
sue chemokine) and Fractalkine seem to have even
more profound effect on T-cell adhesion (31,32).
Chemokines also regulate cellular polarization and
adhesion receptor redistribution during interaction of
activated blood lymphocytes with ICAM-1, VCAM-1
and 38 kd and 80 kd FN fragments (36-39). This was
suggested to represent a mechanism that enhances the
recruitment of lymphocytes to inflammatory foci.
T leukemia lymphocytes from patients exhibit
motile behavior which seems to be pathologically ele-
vated or depressed compared with that of normal
T-cells (40,41). This suggests that there may be dis-
turbances of motility in T-leukemia cells. However, it
is difficult to analyze possible regulatory mechanisms
such as interactions with endothelial cells, ECM-com-
ponents or the influence of chemokines using patient
material. T-leukemia cell lines representing different
stages of differentiation (42) are useful alternative
tools for comparative analysis of T-lymphocyte
migration. Normal T-cell clones may constitute ade-
quate reference cells for such analysis. Investigations
of migratory properties of neoplastic T cell lines mayDEFECTIVE CHEMOKINE PRODUCTION IN T- LEUKEMIA 69
thus elucidate the factors responsible for the abnormal
migration behavior of T-leukemias and lymphomas.
Here we show that T-leukemia cell lines do not pro-
duce endogenous chemokines, while normal T-cell
clones produce high levels of several chemokines and
the motogenic cytokine HGF.
MATERIALS AND METHODS
Chemicals
The following chemicals were purchased: collagen
type IV and laminin (Sigma chemicals Co., St. Louis,
MO). Human plasma fibronectin was purified using
affinity chromatography-gelatin sepharose 4B (Phar-
macia Biotech., Sollentuna, Sweden).
The following human recombinant chemokines
were purchased: GRO- and lymphotactin (Pepro
Tech Inc., Rocky Hill, NJ); MIP-lct, MIP-I and
RANTES (Genzyme Diagnistics, Cambridge, MA).
Cells
All T-leukemia cell lines used in these studies were
purchased from American Type Culture Collection
(ATCC, Rockville, MD). The birch-specific T-cell
clone AF 24 was obtained from J. van Neerven, ALK
Research Laboratory, HCrsholm, Denmark (AF 24).
PBL were isolated as previously described (16).
The neoplastic T-cell lines are immortalized ALL,
except Hut-78 which is a Sezary’s syndrome (42). The
T-cell clones require antigen stimulation and IL-2 and
IL-4, Cells used in the different studies were cultured
in 50 ml or 250 ml Falcon tissue culture flasks (Bec-
ton Dickinson Labware, Franklin Lakes, NJ). PBL, P
30 (T-blast I), CCRF CEM (T-blast II), Jurkat (T-blast
III), MOLT 4 (T-blast III), PEER (T-blast IV) CCRF
HSB2 (T-blast IV) and HuT 78 (T-blast V) were cul-
tured in RPMI-medium 1640 (Gibco Ltd, Paisley,
Scotland) with additives: 10 % heat-inactivated FCS
(Gibco Ltd), 2mM L-glutamine (Seromed, Berlin,
Germany), 50 g/ml bensyl penicillin (Astra,
S6dertilje, Sweden) and 74,5 U/ml streptomycin sul-
fate (Sigma chemicals Co., St. Louis, MO) (referred
to hereafter as complete medium). The T-cell clone
was cultured in RPMI-medium 1640 with additives:
5% FCS + 5% human AB-serum, 2mM L-glutamine,
50 ktg/ml bensyl penicillin, 74,5 U/ml streptomycin
sulfate, IL-2 (10 ng/ml)(Genzyme Diagnostics, Cam-
bridge, MA) and IL-4 (10 ng/ml)(Genzyme Diagnos-
tics). Every second week the T-cell clone was
stimulated with specific antigen or anti-CD-3. The
medium in the cultures were exchanged every 2-3
days.
Modified Boyden microchemotaxis chamber assay
Lymphocyte migration was studied using a modified
Boyden chamber assay system (Neuro Probe, Cabin
John, MA). Briefly, a two chamber system, consisting
of 48 wells, is devided by a filter with pores with a
diameter large enough for cells to be capable to
migrate through. Polyvinylpyrrolidone-free polycar-
bonate filters with 8 tm pore size (Porotics Co.,
Livermore, CA) were coated on the lower surface
overnight with fibronectin 20tg/ml and subsequently
washed in distilled water and air dried. The lower
wells were filled with RPMI containing 10% FCS.
The upper wells were filled with 50 tl cells (2106
cells/ml) in RPMI with 10% FCS.
The chambers were incubated for 5 hours in a
humidified incubator at 37C. Following incubation
the filters were removed, fixed in methanol and
stained with Giemsa (Reidel-de Ha6n, Seeize, Ger-
many).
The filters were subsequently placed onto glass
slides and remaining cells on the upper side of the fil-
ter were wiped off. The numbers of migrated cells
were counted by light microscopy using a magnifica-
tion of x200.
In order to analyze chemotactic effects of chemok-
ines, chemokines were added at different concentra-
tions to the medium in the lower wells. Each
experiment was done in triplicate (three wells/con-
centration). The results are presented as mean values.70 JYRKI IVANOFF et al.
ELISA assay
ELISA analysis of chemokines/cytokines in condi-
tioned media from the different T-cell lines/clones
were performed using different Quantikine
TM
immu-
noassay kits (R&D Systems, Minneapolis, MN).
RESULTS
Chemokine production by normal and neoplastic
T lymphocytes
The production of various chemokines by peripheral
blood lymphocytes, T-cell clones and various neo-
plastic T lymphocyte cell lines representing different
stages of T-cell differentiation was compared. The
production of chemokines was determined in condi-
tioned media using specific ELISA assays. It is evi-
dent from the ELISA assays shown in table I that the
blood T-cells and a representative T-cell clone pro-
duced and released chemokines including RANTES,
MIP-1 and , MCP-1, IL-8 and GRO- into the cul-
ture medium. In addition, the motogenic cytokine
HGF was detected in conditioned medium from the
T-cell clone AF 24. Table I further shows that none of
the different neoplastic T-cell lines produced any of
the chemokines tested. We have also made several
attempts to detect chemokines in conditioned media
of neoplastic T lymphocytes after stimulation with
forbol ester and cytokines (IL-2 and IL-4). All these
attempts yielded negative results (data not shown). In
conclusion, therefore normal T lymphocytes had a
substantial chemokine production while neoplastic
T-cells did not seem to produce chemokines.
Chemokine responsiveness of normal and
neoplastic T lymphocytes
The influence of the chemokines RANTES, MIP-1[
and IL-8 on the migration of the T leukemia cell lines
MOLT 4 and Jurkat, using the Boyden chamber assay
system, was studied (fig 1). The lymphocytes showed
little migration on non-coated filters but migrated
well on fibronectin coated filters. It is evident from
the results presented in fig 1 that RANTES MIP-I[
and IL-8 provoked a strong chemotactic effect on
lymphocyte migration on fibronectin. The T-leukemia
cell lines showed dose-response curves to chemok-
ines which usually had peak responses at 1-50 ng/ml.
One T lymphocyte clone (AF 24) was tested and
showed weaker migratory responses than the leuke-
mic cell lines. Noteworthy, this T-cell clone showed
peak responses at chemokine concentrations above
100 ng/ml (not shown).
TABLE The concentration of chemokines and cytokines in conditioned media from different T-leukemia cell lines
IL-8 MCP-1 GRO- MIP-I MIP-I RANTES IGF-I HGF
Concentration (pg/ml)
P30 0 0 0 0 0 21 0 0
CCRF CEM 47 0 11 0 0 0 0 0
Jurkat 0 0 0 0 0 0 0 0
MOLT 4 0 0 0 0 0 0 0 0
PEER 0 0 0 0 0 0 0 0
CCRF HSB2 0 0 0 0 0 0 0 0
HuT 78 0 0 0 0 0 0 0 0
Normal T-cell clone (AF 24) >4000 261 10 > 12000 1856 > 5600 0 245
PBL >60000 NA NA >2600 1123 82 NA NA
The concentration of chemokines and cytokines in conditioned media from different T-leukemia cell lines, T cell elones and PBL was
analysed The media from the leukemia cell lines were conditioned for 72 hrs whereas the medium from the normal T-cell clone and PBL
was conditioned for 48 hrs. The results show that the leukemia T-cell lines studied either did not produce or merely produced very low
levels of chemokines or motogenic cytokines while the normal T-cell clone produced a considerable amount of IL-8, MCP-1, MIP-la,
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FIGURE Migration of MOLT 4 and Jurkat T-cell lines in Boyden chemotaxis assay through filters coated on the lower surface with
fibronectin 20 gg/ml (indicated as coat=C) in the absence and presence of chemokines in the lower well as described in the figure
Locomotor behaviour of T-leukemia cell lines
The motile behaviour of the T-leukemia cell lines
MOLT 4 and Jurkat on fibronectin in the absence and
presence of chemokines was compared. The result of
the comparison is summarized in fig 2. The different
cell lines exhibited typical individual characteristics
in cell shape. For example MOLT 4 showed a charac-72 JYRKI IVANOFF et al.
teristic bipolar shape on fibronectin and Jurkat under-
went cytoplasmic spreading with multiple
pseudopodia on the same substratum. The presence of
chemokines at concentrations promoting migration
according to fig 1 augmented the number of adherent
cells on fibronectin as previously reported by others
(10,19-21,23-27,29) (data not shown). However, it
can be seen in fig 2 that the chemokines did not aug-
ment the number of motile forms. Thus, the chemok-
ines did not exert any obvious potentiating effect on
the motile shape of the cells or on the development of
pseudopodia. Furthermore, in some cases chemokines
seemed to decrease the number of motile cells.
DISCUSSION
The major conclusion from the present study is that
T-leukemia cell lines seem to have defective chemok-
ine production. The data presented in this report thus
establish that antigen-specific T-cell clones (table I)
produce the chemokines RANTES, MIP- , MIP- ,
IL-8 and MCP-1 as well as the motogenic cytokine
HGE In contrast, a number of leukemic T-cell lines
did not produce chemokines The absence of chemok-
ine production in T-leukemia cell lines represents a
loss of a class of molecules implicated in the control
of cell motility in comparison with "normal" T-cells.
However, in spite of the fact that the T-leukemia cell
lines did not produce chemokines this defective
chemokine production did not seem to influence the
basic locomotor capacity of the cells .defined as devel-
opment of motile forms and pseudopodia. Notewor-
thy, exogenous chemokines presented in the lower
well of Boyden chambers promoted migration of
T-leukemia cell lines showing that they possess
capacity to respond to chemokines.
The T-leukemia cell lines showed peak migratory
responses at lower chemokine concentrations than the
"normal" T-cell clone. The difference in optimal
chemokine concentrations for a motile response
between separate cell types including normal and
neoplastic T lymphocytes is not understood. Normal
blood T-cells show maximal cytokine responses at 1
ng/ml and RANTES attract monocytes optimally at a
concentration of 100 ng/ml (49). One possible expla-
nation for the different dose-response profile to chem-
okines between T-leukemia cells and T lymphocyte
clones may be that endogenous chemokines downreg-
ulate the chemokine responses of the normal cells by
binding to chemokine receptors and that this binding
either blocks or causes modulation/disappearance of
the receptors. The literature contains numerous exam-
ples of up- and downregulation of growth fac-
tor/cytokine receptors by their ligands (26).
The present data point to the possibility that normal
and neoplastic T lymphocytes may differ in their
responses to chemokines although this needs further
investigation. Such investigations should focus on the
influence of continuous chemokine exposure on the
expression of chemokine receptors by T-leukemia
cells lacking endogenous chemokines. Does such lig-
and exposure modulate chemokine receptor expres-
sion per se or the sensitivity of chemokine receptors
to their ligands? Understanding of possible differ-
ences in the mechanisms of chemokine action
between normal and neoplastic T lymphocytes proba-
bly requires more experimental information concern-
ing chemokine receptors in the same cells.
The fact that T-leukemia cells do not produce
chemokines and other motogenic cytokines implies
that they lack a regulatory system of endogenous
mediators of migration which is present in normal
T-cells. Normal T-cell clones, as observed in this
study, can migrate chemotactically to their own chem-
okines. In non-lymphoid cell systems several auto-
crine motility factors have been described and
characterized (50,51). These have been proposed to
induce cell motility in normal situations such as heal-
ing and embryogenesis and to confer metastatic capa-
bilities on neoplastic cells. However, a possible
consequence of the lack of endogenous chemokines
may be that T-leukemia cells display hyperrespon-
siveness to environmental chemokines.
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